Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-10-03Clinical Trial Update: A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants [Phase 1]
A first-in-human Phase 1 study evaluating the safety and tolerability of GSK3996401 after dosing with GSK4347859 in healthy participants has…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS other · 2025-10-02Clinical Trial Update: HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms [NA]
Clinical trial update for HEAL-SLE shows the NYU Langone Health-sponsored study investigating Systemic Lupus Erythematosus is not yet recrui…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Comparative Autoantibody and Immunologic Cell Marker Study
This clinical trial update describes an ongoing study assessing autoantibody profiles and immune cell markers in autoimmune diseases, includ…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease [Phase 1, Phase 2]
Miltenyi Biomedicine is conducting Phase 1/2 trials of CAR-T cell therapy targeting B cells for autoimmune diseases, including systemic lupu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Engagement in CHildhood-Onset Systemic Lupus [NA]
A clinical trial at Montefiore Medical Center is enrolling by invitation for childhood-onset systemic lupus erythematosus, with depression a…
-
CLINICAL_TRIALS other · 2025-09-30Clinical Trial Update: Intervention to Improve Communication and Medication Adherence in Lupus [NA]
A Duke University–sponsored clinical trial is recruiting to evaluate an intervention aimed at improving communication and medication adheren…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update assessing a dual CD19/BCMA-targeted CAR T-cell therapy for relapse/refractory autoimmune diseases, currently r…
-
CLINICAL_TRIALS other · 2025-09-29Clinical Trial Update: Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)
This clinical trial update indicates that the expanded access IND for autologous HB-adMSCs to treat systemic lupus erythematosus is no longe…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus [Phase 3]
Phase 3 trial update examining the efficacy and safety of sirolimus in active systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Vagus Nerve Stimulation for Systemic Lupus Erythematous [NA]
A completed clinical trial investigating vagus nerve stimulation for systemic lupus erythematosus with autonomic dysfunction.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
A clinical trial from Peking University People's Hospital evaluating mass spectrometry-based immune profiling across autoimmune diseases; th…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients [NA]
Protocol for developing a dietary intervention model based on genetic data to support healthy lifestyle management in systemic lupus erythem…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus [Phase 1]
Phase 1 study of KK4277 in healthy volunteers and patients with systemic lupus erythematosus and cutaneous lupus erythematosus; the trial is…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Centrally Acting ACE Inhibition in SLE [Phase 2]
Phase 2 clinical trial update on centrally acting ACE inhibition for Systemic Lupus Erythematosus; current status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS withdrawal · 2025-09-19Clinical Trial Update: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) [Phase 1]
This Phase 1 trial investigating a CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy for systemic lupus erythematosus has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Estimate of the Activity and the Forecast of the Lupus Disease of the Adult by a Transcriptomic Score (STUDY LU-PUCE) [NA]
Completed clinical trial update on estimating lupus activity in adults using a transcriptomic score (LU-PUCE).
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Psycho-social Consequences of Systemic Lupus Erythematosus
A completed clinical trial investigating psycho-social consequences of systemic lupus erythematosus.
-
CLINICAL_TRIALS other · 2025-09-17Clinical Trial Update: Safety Study of CC312 in Autoimmune Disease Patients [EARLY_Phase 1]
Early-phase safety study of CC312 in multiple autoimmune diseases is currently recruiting, sponsored by CytoCares Inc.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Safety and Efficacy Study of CC312 for Moderate to Severe SLE [Phase 1]
Clinical trial update for a Phase 1 safety and efficacy study of CC312 in moderate to severe systemic lupus erythematosus, with recruitment …
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical study evaluating A-319 for active or refractory systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s) [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in partici…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: LUpus Eritematoso Sistemico NETwork and Registry
An Italian clinical trials network and registry for systemic lupus erythematosus (SLE) that is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory study evaluating BZE2204 CAR-T cells targeting CD19/CD22/BCMA for relapsed or refractory autoimmune diseases, cur…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients [Phase 1]
A Phase 1 UC-MSC cell therapy trial for systemic lupus erythematosus is currently recruiting.